Cooper Current Deferred Revenue from 2010 to 2026

COO Stock  USD 71.52  -2.89  -3.88%   
Current Deferred Revenue is evolving in a expanding direction across reporting periods. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
 First Reported
2001-01-31
 Previous Quarter
127.9 M
 Current Value
129.9 M
 Quarterly Volatility
96.6 M
Macro event markers
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Financial statement trends for Cooper Companies provide structured context on operating performance and capital structure. The series highlights drivers like Depreciation And Amortization of 510.8 M, Interest Expense of 94.5 M or Selling General Administrative of 2 B and ratios such as Price To Sales Ratio of 2.3, Dividend Yield of 2.0E-4 or PTB Ratio of 1.44, complementing Cooper Companies Valuation and Volatility.
  
Build AI portfolio with Cooper Stock
Cooper Companies Correlation provides competitor comparison context for Cooper Companies. This supports competitive context.
Evaluating Cooper Companies's Current Deferred Revenue across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into The Cooper Companies's fundamental strength.

Latest Cooper Companies' Current Deferred Revenue Growth Pattern

Below is the plot of the Current Deferred Revenue of The Cooper Companies over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Cooper Companies' Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cooper Companies' overall financial position and show how it may be relating to other accounts over time.
Current Deferred Revenue10 Years Trend
Slightly volatile
   Current Deferred Revenue   
       Timeline  

Cooper Current Deferred Revenue Regression Statistics

Arithmetic Mean-20,760,029
Coefficient Of Variation-584.11
Mean Deviation 113,133,969
Median-85,056,000
Standard Deviation 121,261,568
Sample Variance14704.4T
Range305.9M
R-Value 0.65
Mean Square Error9098.7T
R-Squared 0.42
Significance 0.0049
Slope 15,560,600
Total Sum of Squares235269.9T

Cooper Current Deferred Revenue History

2026120.9 M
2025115.1 M
2024127.9 M
2023129.9 M
2022123.6 M
202193.6 M
202019 M

About The Cooper Companies, Inc

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California. Cooper Companies operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 14000 people. This stock section frames Cooper Companies within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/E of 35.89, P/B of 1.72, profit margin of 9.67%. Cooper Companies has a market cap of 14.39 B, P/E of 35.89, ROE of 4.87%.

Methodology

Unless otherwise specified, financial data for The Cooper Companies is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Cooper (USA Stocks:COO) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report references public filings and market reference sources and institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Certain datasets may update with delay depending on source availability. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

The Cooper Companies is covered by 19 analysts. 9 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Stifel, Barclays, Morgan Stanley, Wells Fargo Securities, Evercore ISI, BMO Capital Markets, HSBC Global Research, Jefferies, J.P. Morgan, Bernstein Research, among others. Updates may occur throughout the day.

Pair Trading with Cooper Companies

Pair trading with Cooper Companies can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Moving against Cooper Stock

  0.68CLYYF Celyad Oncology SAPairCorr
  0.52DEVM Devmar EquitiesPairCorr
  0.48TTCM TautachromePairCorr
  0.33CITAF COSCO SHIPPINGPairCorr
Sophisticated investors use correlation analysis to build Cooper Companies replacement strategies that go beyond simple sector matching. Assets with similar factor exposures to The Cooper Companies provide the most accurate portfolio substitution during tax-loss harvesting periods.
Statistical correlation between Cooper Companies and its peers is an essential input for mean-variance portfolio optimization. Lower correlation of Cooper Companies with other holdings allows for a more efficient frontier with superior risk-adjusted returns.
Correlation analysis and pair evaluation for Cooper Companies can support hedging context. This approach is commonly reviewed within sectors and across broader groups.
Pair CorrelationCorrelation Matching

More Resources for Cooper Stock Analysis

A comprehensive view of Cooper Companies starts with financial statements and ratio context. Ratios and trend metrics help frame Cooper Companies' operating context. Highlighted below are reports that provide context for The Cooper Companies Stock:
Cooper Companies Correlation provides competitor comparison context for Cooper Companies. This supports competitive context.
Analysis related to Cooper Companies should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
 Quarterly Earnings Growth
0.269
 Earnings Share
2.01
 Revenue Per Share
20.955
 Quarterly Revenue Growth
0.062
 Return On Assets
0.0364
Understanding Cooper Companies includes distinguishing between market value and book value, where book value reflects Cooper accounting equity. Cooper Companies' market capitalization is 14.39 B. A P/B ratio of 1.72 indicates the market values Cooper Companies above its accounting book value. Enterprise value stands at 16.89 B. Intrinsic value is an estimate of what Cooper Companies' fundamentals imply, and it may differ from market and book figures. Analytical frameworks help compare those viewpoints.
The concept of value for Cooper Companies differs from its quoted price, since each reflects a different lens. For Cooper Companies, key inputs include a P/E ratio of 35.89, a P/B ratio of 1.72, a profit margin of 9.67%, and ROE of 4.87%. Market price reflects the current exchange level formed by active bids and offers.